Rietbergen JB - Search Results

1

Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study.

van den Bergh RC, Vasarainen H, van der Poel HG, Vis-Maters JJ, Rietbergen JB, Pickles T, Cornel EB, Valdagni R, Jaspars JJ, van der Hoeven J, Staerman F, Oomens EH, Rannikko A, Roemeling S, Steyerberg EW, Roobol MJ, Schröder FH, Bangma CH. van den Bergh RC, et al. Among authors: rietbergen jb. BJU Int. 2010 Apr;105(7):956-62. doi: 10.1111/j.1464-410X.2009.08887.x. Epub 2009 Oct 8. BJU Int. 2010. PMID: 19817747

2

Prospective evaluation plan for randomised trials of prostate cancer screening. The International Prostate Cancer Screening Trial Evaluation Group.

Auvinen A, Rietbergen JB, Denis LJ, Schröder FH, Prorok PC. Auvinen A, et al. Among authors: rietbergen jb. J Med Screen. 1996;3(2):97-104. doi: 10.1177/096914139600300211. J Med Screen. 1996. PMID: 8849769

3

Evaluation of prostate-specific antigen, digital rectal examination and transrectal ultrasonography in population-based screening for prostate cancer: improving the efficiency of early detection.

Rietbergen JB, Kranse R, Kirkels WJ, De Koning HJ, Schröder FH. Rietbergen JB, et al. Br J Urol. 1997 Apr;79 Suppl 2:57-63. doi: 10.1111/j.1464-410x.1997.tb16922.x. Br J Urol. 1997. PMID: 9126071 Clinical Trial. No abstract available.

4

Prostate-specific antigen as a screening test. The Netherlands experience.

Bangma CH, Rietbergen JB, Schröder FH. Bangma CH, et al. Among authors: rietbergen jb. Urol Clin North Am. 1997 May;24(2):307-14. doi: 10.1016/s0094-0143(05)70377-3. Urol Clin North Am. 1997. PMID: 9126228 Clinical Trial.

5

Screening for prostate cancer.

Kirkels WJ, Rietbergen JB. Kirkels WJ, et al. Among authors: rietbergen jb. Urol Res. 1997;25 Suppl 2:S53-6. doi: 10.1007/BF00941988. Urol Res. 1997. PMID: 9144887 Review.

6

The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population.

Bangma CH, Rietbergen JB, Kranse R, Blijenberg BG, Petterson K, Schröder FH. Bangma CH, et al. Among authors: rietbergen jb. J Urol. 1997 Jun;157(6):2191-6. J Urol. 1997. PMID: 9146612 Clinical Trial.

7

Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program.

Rietbergen JB, Kruger AE, Kranse R, Schröder FH. Rietbergen JB, et al. Urology. 1997 Jun;49(6):875-80. doi: 10.1016/s0090-4295(97)00100-3. Urology. 1997. PMID: 9187694 Review.

8

Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer.

Hoedemaeker RF, Rietbergen JB, Kranse R, van der Kwast TH, Schröder FH. Hoedemaeker RF, et al. Among authors: rietbergen jb. World J Urol. 1997;15(6):339-45. doi: 10.1007/BF01300181. World J Urol. 1997. PMID: 9436283 Clinical Trial.

9

Comparison of prostate-specific antigen corrected for total prostate volume and transition zone volume in a population-based screening study.

Rietbergen JB, Kranse R, Hoedemaeker RF, Kruger AE, Bangma CH, Kirkels WJ, Schröder FH. Rietbergen JB, et al. Urology. 1998 Aug;52(2):237-46. doi: 10.1016/s0090-4295(98)00138-1. Urology. 1998. PMID: 9697788 Clinical Trial.

10

Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and pathological features of detected cancer.

Rietbergen JB, Kruger AE, Hoedemaeker RF, Bangma CH, Kirkels WJ, Schröder FH. Rietbergen JB, et al. J Urol. 1998 Dec;160(6 Pt 1):2121-5. doi: 10.1097/00005392-199812010-00046. J Urol. 1998. PMID: 9817336 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page